These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2563628)

  • 21. [24-hour intragastric acid profile in a ZES patient with H2 blockers].
    Dammann HG; Müller P; Simon B; Kommerell B
    Z Gastroenterol; 1984 Jun; 22(6):318-20. PubMed ID: 6147052
    [No Abstract]   [Full Text] [Related]  

  • 22. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A; Barbara L; Bianchi-Porro G; Blasi A; Canelli B; Cheli R; Dal Monte R; Dammann HG; Francavilla A; Hentschel E
    Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylaxis against acid aspiration syndrome. Single oral dose of H2-antagonist on the evening before elective surgery.
    Gallagher EG; White M; Ward S; Cottrell J; Mann SG
    Anaesthesia; 1988 Dec; 43(12):1011-4. PubMed ID: 2906783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Famotidine (Pepcid).
    Med Lett Drugs Ther; 1987 Feb; 29(733):17-8. PubMed ID: 2880282
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of famotidine and ranitidine in duodenal ulcer].
    Rohner HG; Gugler R; Kimmig JM; Schönekäs H
    Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704
    [No Abstract]   [Full Text] [Related]  

  • 26. Surgery and clinical progression in patients with Crohn's disease of the small and large intestine.
    Goldstein MJ; Schachter H; Kirsner JB
    Am J Surg; 1968 Mar; 115(3):376-84. PubMed ID: 5300345
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine.
    Aoki T
    J Int Med Res; 1989; 17 Suppl 1():32A-40A. PubMed ID: 2566542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
    Tomasko MA; Luskin AT
    Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
    [No Abstract]   [Full Text] [Related]  

  • 29. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
    Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacy intern intervention to reduce costs associated with histamine H2-antagonist therapy.
    Algozzine GJ; Sprenger RL; Caselnova DA; Proper P
    Am J Hosp Pharm; 1989 Jun; 46(6):1183-4. PubMed ID: 2568750
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies.
    Kim J; Ogai A; Nakatani S; Hashimura K; Kanzaki H; Komamura K; Asakura M; Asanuma H; Kitamura S; Tomoike H; Kitakaze M
    J Am Coll Cardiol; 2006 Oct; 48(7):1378-84. PubMed ID: 17010798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children.
    Miyake S; Yamada M; Iwamoto H; Yamashita S; Sugio Y
    Clin Ther; 1987; 9(5):548-58. PubMed ID: 2889529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bypass compared with resection for ileal Crohn's disease.
    Koudahl G; Kristensen M; Lenz K
    Scand J Gastroenterol; 1974; 9(2):203-6. PubMed ID: 4818398
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical importance of the new H2-antagonists.
    Walt RP
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Accelerated healing of ulcus ventriculi by a single evening dose of famotidine. Results of an Austrian-German-Italian multicenter study].
    Dammann HG; Barbara L; Bianchi-Porro G; Cheli R; Hentschel E; Müller P; Paoluzzi P; Simon B; Walter TA
    Schweiz Med Wochenschr; 1985 Apr; 115(14):484-8. PubMed ID: 2859653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of oral and intramuscular famotidine on pH and volume of gastric contents.
    Abe K; Shibata M; Demizu A; Hazano S; Sumikawa K; Enomoto H; Mashimo T; Tashiro C; Yoshiya I
    Anesth Analg; 1989 Apr; 68(4):541-4. PubMed ID: 2564752
    [No Abstract]   [Full Text] [Related]  

  • 37. [Some sequelae of definitive ileostomy and of ileo-rectostomy].
    Servino G
    Ann Ital Chir; 1979; 51(6):675-88. PubMed ID: 547776
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombotic thrombo-cytopenic purpura associated with histamine H2-receptor antagonist therapy.
    Kallal SM; Lee M
    West J Med; 1996 May; 164(5):446-8. PubMed ID: 8686308
    [No Abstract]   [Full Text] [Related]  

  • 39. Glucose polymer solution for diarrhea in ileostomates.
    Meyer GW
    Am J Gastroenterol; 1989 Aug; 84(8):991. PubMed ID: 2756998
    [No Abstract]   [Full Text] [Related]  

  • 40. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.